Scarica l'app Stockscreener
5.80
2.36%
-0.14
Annexon Inc Borsa (ANNX) Ultime notizie
Price to book forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Enterprise value to EBITDA forward of Annexon, Inc. – BOATS:ANNX - TradingView
Price to earnings forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Redmile Group (ANNX) reports 9.9% stake; RedCo II Offshore at 5.5% - Stock Titan
FMR LLC reports 11.9% stake in Annexon (NASDAQ: ANNX) - Stock Titan
Does Annexon’s Shift Into Russell Growth Indices Recast Its Core Equity Story for Investors (ANNX)? - simplywall.st
Annexon (ANNX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Annexon unveils eight research posters on Guillain-Barré syndrome and tanruprubart at EAN2026 - Traders Union
ANNXAnnexon Inc Options - Finviz
ANNX Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline, but Stock SlipsGuidance Downgrade Alert - dars.gov.et
Needham Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Annexon, Inc.(NasdaqGS: ANNX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Annexon, Inc.(NasdaqGS: ANNX) added to Russell 2500 Growth Benchmark - marketscreener.com
Annexon, Inc.(NasdaqGS: ANNX) dropped from Russell 2000 Value Benchmark - marketscreener.com
Annexon, Inc.(NasdaqGS: ANNX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Annexon, Inc.(NasdaqGS: ANNX) added to Russell 2000 Growth Benchmark - marketscreener.com
Annexon, Inc.(NasdaqGS: ANNX) added to Russell 3000E Growth Benchmark - marketscreener.com
ANNX Forecast — Price Target — Prediction for 2027 - TradingView
Annexon, Inc. Actuals & Estimates (NASDAQ:ANNX) - TradingView
Annexon, Inc.'s (NASDAQ:ANNX) Profit Outlook - 富途牛牛
ANNX Q1 2026 Earnings: Narrower Loss Than Expected, Stock Rises 4.8%Earnings Yield Analysis - dars.gov.et
Annexon Inc (ANNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Annexon (ANNX) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Annexon (ANNX) AGM 2026 Summary - Quartr
ANNX Q1 2026 Earnings: Beats EPS Estimates but Stock DeclinesRevenue Growth Report - dars.gov.et
Annexon unveils six Guillain-Barre syndrome studies at PNS2026 global forum - Traders Union
ANNX Stock Price, Quote & Chart - ChartMill
ANNX News | ANNEXON INC (NASDAQ:ANNX) - ChartMill
Annexon Inc (ANNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Annexon Inc (ANNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Annexon Inc (ANNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Annexon Inc (ANNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Annexon Inc (ANNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Annexon Inc (ANNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Annexon Inc (ANNX) Institutional Confidence - TradingKey
Annexon Inc (ANNX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Annexon Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Annexon (ANNX) director William Waddill receives 65,000 stock options grant - Stock Titan
Annexon (NASDAQ: ANNX) director receives 65,000-share stock option grant - Stock Titan
[Form 4] Annexon, Inc. Insider Trading Activity - Stock Titan
Annexon (ANNX) director Bettina Cockroft awarded 65,000 stock options at $4.70 - Stock Titan
Annexon (ANNX) grants director Jung Choi 65,000 stock options at $4.70 - Stock Titan
Annexon (ANNX) director William Carson receives 65,000 stock options at $4.70 - Stock Titan
Annexon (NASDAQ: ANNX) EVP exercises stock options, lifts stake to 184,807 shares - Stock Titan
ANNX Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionEarnings Sentiment Score - newsline.com
Annexon Stockholders Approve Directors, Compensation and Share Increase - The Globe and Mail
Annexon Inc. (ANNX) Holds Steady Near Support as Biotech Sector Faces HeadwindsRisk Parity Rebalance - newsline.com
Annexon (NASDAQ: ANNX) reports 2026 annual meeting vote outcomes - Stock Titan
Annexon Inc. (ANNX) Gains 2.13% as Biotech Stock Holds Above Key SupportCounter Trend Trade - newsline.com
ANNX: All proposals passed as late-stage therapies advance and cash runway extends into 2027 - TradingView
Annexon Inc Annual Shareholders Meeting Transcript - GuruFocus
Annexon eyes 'win season' with Q4 vision trial data, GBS filings ahead - MSN
Annexon maps 3 big pipeline catalysts ahead of Q4 vision-drug readout - MSN
Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead - MarketBeat
Annexon Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout - sharewise.com
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):